XML 33 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1

Lease Exit Liability - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	May 10, 2016
Restructuring Cost and Reserve [Line Items]
Reduction in research and development expense	$ 1.3
Raven Biotechnologies Inc
Restructuring Cost and Reserve [Line Items]
Future sublease payments to be received		$ 1.3

X

- Definition

Reduction in R&D expense recorded in period

+ References

No definition available.

+ Details

Name:	mgnx_ReductionInRDExpense
Namespace Prefix:	mgnx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Contractually required future rental payments receivable on noncancelable subleasing arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name:	us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_RestructuringCostAndReserveLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=mgnx_RavenBiotechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: